NYSE:MDT
97.10
0.15
(0.15%)
Analysis and Opinions about MDT-N
Signal
Opinion
Expert
BUY
BUY
September 8, 2008
Likes medical devices sector. Of all the sectors, medical equipment is one of the tops. Regardless of what is going on in the economies , medical devices will continue to sell. He owns Zoll Medical (ZOLL-Q) instead, which has more growth potential. Thinks there is more upside potential in the small/mid-cap size names.
Show full opinionHide full opinion
Likes medical devices sector. Of all the sectors, medical equipment is one of the tops. Regardless of what is going on in the economies , medical devices will continue to sell. He owns Zoll Medical (ZOLL-Q) instead, which has more growth potential. Thinks there is more upside potential in the small/mid-cap size names.
BUY
BUY
March 22, 2007
PE of about 20 and anticipated growth rate of about 14%. Have a lot of intellectual property. Reasonably attractive.
Show full opinionHide full opinionPE of about 20 and anticipated growth rate of about 14%. Have a lot of intellectual property. Reasonably attractive.
DON'T BUY
DON'T BUY
January 17, 2007
His model price is $41.45 so it is a negative 23%-24% differential. This is one of those stocks that is perpetually overvalued.
Show full opinionHide full opinionHis model price is $41.45 so it is a negative 23%-24% differential. This is one of those stocks that is perpetually overvalued.
BUY
BUY
September 27, 2006
Likes a lot of the big US healthcare stocks. Valuation is reasonable.
Show full opinionHide full opinionLikes a lot of the big US healthcare stocks. Valuation is reasonable.
BUY WEAKNESS
BUY WEAKNESS
July 11, 2006
On his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.
Show full opinionHide full opinionOn his watch list as a possible investment. Valuation has been hurt but the fundamentals have not changed much. The long-term outlook for their products is very good.
TOP PICK
TOP PICK
July 30, 2004
A high quality, growth company. Good price. The leading medical technology company in the world.
Show full opinionHide full opinionA high quality, growth company. Good price. The leading medical technology company in the world.
TOP PICK
TOP PICK
July 2, 2004
Solid earnings. Feels their new stent will be successful next year.
Show full opinionHide full opinionSolid earnings. Feels their new stent will be successful next year.
DON'T BUY
DON'T BUY
February 10, 2004
Interesting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely
Show full opinionHide full opinionInteresting company. Market is very strong for their products. Stock isn't cheap. Has been growing slowely
DON'T BUY
DON'T BUY
September 8, 2003
Valuation is a little bit ahead of the stock. Very good management.
Show full opinionHide full opinionValuation is a little bit ahead of the stock. Very good management.
DON'T BUY
DON'T BUY
Competition. Too expensive at 30 X earnings.
BUY WEAKNESS
BUY WEAKNESS
Great company. Buy in the mid to low $20's.
TOP PICK
TOP PICK
Good company. Not a cheap stock. A cash machine.
BUY
BUY
Good price now. Good mngmnt.
PAST TOP PICK
PAST TOP PICK
July 5, 2001
Good acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.
Show full opinionHide full opinionGood acquisition. Fairly expensive, but the dominant player. No debt. Good dividends.
BUY
BUY
Just bought minimal. Cheap.
BUY
BUY
April 30, 2001
Decent price now. Buying a little now in mid-40's, but would buy a lot more in the 30's. Lots of cash.
Show full opinionHide full opinionDecent price now. Buying a little now in mid-40's, but would buy a lot more in the 30's. Lots of cash.
BUY
BUY
Bullet proof portfolio-small caps(25%)
BUY
BUY
Has dropped from their highs.
BUY
BUY
February 14, 2001
No debt. Competition is large US companies, but they make money and the stock has grown. Good long term
Show full opinionHide full opinionNo debt. Competition is large US companies, but they make money and the stock has grown. Good long term
